No Photo Available

Last Update

2017-02-21T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Stephen Squinto?

Dr. Stephen P. Squinto

Venture Partner

OrbiMed Advisors LLC

Direct Phone: (212) ***-****       

Email: s***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

OrbiMed Advisors LLC

601 Lexington Avenue 54th Floor

New York City, New York 10022

United States

Company Description

OrbiMed is a leading investment firm dedicated exclusively to the healthcare sector, with over $14 billion in assets under management. OrbiMed invests globally across the spectrum of healthcare companies, from venture capital start-ups to large multinatio ... more

Find other employees at this company (156)

Background Information

Affiliations

Board Member
New Haven Symphony Orchestra

Board Member
audentes therapeutics, inc.

Co-Founder
Lyfebulb Inc

Board Member
TherAchon AG

Board Member
Nutrinia Ltd

Board Member
SmartZyme

Board of Directors of the Regional Chapter
JDRF

Board Member
Generation UCAN

Lyfebulb Executive Board Member
Social Club

Executive Vice President and Head of Research and Development
Alexion Pharmaceuticals Inc

Co-Founder
Enobia Pharma Inc.

Education

B.A.

Chemistry

Loyola University of Chicago

Ph.D.

Ph.D.

Biochemistry and Biophysics

Loyola University of Chicago

bachelor's degree

chemistry

Loyola University

doctorate degree

biochemistry and biophysics

Loyola University

Web References (153 Total References)


Board of Directors - Audentes Therapeutics

audentestx.com [cached]

Stephen Squinto, Ph.D.

Stephen Squinto, Ph.D., has over 25 years of experience in the biotechnology industry, as both a scientist and senior executive. He is currently a Venture Partner with OrbiMed. Dr. Squinto was a co-founder of Alexion Pharmaceuticals Inc. and recently served as its Executive Vice President and Chief Global Operations Officer. Prior to 2013, he was Alexion's Global Head of Research and Development. Alexion is dedicated to developing therapies for certain rare and ultra-rare diseases. From 1988 to 1992, Dr. Squinto held various positions at Regeneron Pharmaceuticals, Inc. Prior to Regeneron, he held a joint academic position at both the Tulane University and LSU Medical Schools. He is a recipient of numerous honors and awards from academic and professional organizations for his scientific work.
Dr. Squinto received his B.A. in Chemistry and Ph.D. in Biochemistry and Biophysics from Loyola University of Chicago.


Venture Partners

www.orbimedadvisors.com [cached]

Stephen Squinto, Ph.D. Venture Partner


Stephen Squinto, ...

lyfebulb.com [cached]

Stephen Squinto, PhD Co-Founder Lyfebulb, Venture Partner at Orbimed

Dr. Squinto has over 25 years of biotechnology industry experience, and has received numerous honors and awards from academic and professional organizations for his scientific work. Dr. Squinto received his B.A. in Chemistry and Ph.D. in Biochemistry and Biophysics from Loyola University of Chicago. Dr. Squinto was a co-founder of Alexion Pharmaceuticals, Inc. and recently served as its Executive Vice President and Chief Global Operations Officer. Prior to 2013 he was Alexion's Global Head of Research and Development. From 1988 to 1992, Dr. Squinto held various positions at Regeneron Pharmaceuticals, Inc. Prior to Regeneron, he held a joint academic position at both the Tulane University and LSU Medical Schools. Since 2015, Dr Squinto has been a venture partner at Orbimed, where he serves as a board member of a number of portfolio companies in the life sciences space.
Stephen Squinto, PhD Co-Founder Lyfebulb, Venture Partner at Orbimed


TherAchon | Achieving Potential

therachon.com [cached]

Stephen Squinto

Stephen Squinto, Ph.D., is a Venture Partner with OrbiMed who brings over 25 years of biotechnology industry experience.
Full Bio ยป
Stephen Squinto
Stephen Squinto, Ph.D., is a Venture Partner with OrbiMed who brings over 25 years of biotechnology industry experience.
Squinto was a co-founder of Alexion Pharmaceuticals, Inc. and recently served as its Executive Vice President and Chief Global Operations Officer. Prior to 2013, he was Alexion's Global Head of Research and Development. From 1988 to 1992, Dr. Squinto held various positions at Regeneron Pharmaceuticals, Inc. Prior to Regeneron, he held a joint academic position at both the Tulane University and LSU Medical Schools. He is a recipient of numerous honors and awards from academic and professional organizations for his scientific work. Dr. Squinto received his B.A. in Chemistry and Ph.D. in Biochemistry and Biophysics from Loyola University of Chicago.


Audentes Therapeutics ...

www.talent4boards.com [cached]

Audentes Therapeutics announces Steve Squinto to the Board as Independent Director Audentes Therapeutics announces Steve Squinto to the Board as Independent Director Talent4Boards

...
HomeBoard - USA / Can.Board Privately Held CompaniesAudentes Therapeutics announces Steve Squinto to the Board as Independent Director
Audentes Therapeutics announces Steve Squinto to the Board as Independent Director
April 21, 2015 By Talent4Boards Team Comments are Off Board - USA / Can., Board Privately Held Companies
- USA, CA - Audentes Therapeutics, Inc., a biotechnology company committed to the development and commercialization of gene therapy products for patients with serious, rare diseases, today announced the appointment of Stephen Squinto, Ph.D., to the company's Board of Directors. Dr. Squinto, a co-founder of Alexion Pharmaceuticals, Inc., will serve as an independent director to Audentes.
"Steve is a pioneer in bringing innovative therapies to patients with rare diseases.
...
"On behalf of the rest of the Board of Directors and the management team, I welcome Steve to Audentes."
"Audentes is an exciting company that is poised to bring highly innovative treatments to patients and to further establish itself as a leader in the gene therapy field," commented Stephen Squinto, Ph.D. "I am pleased to join the board and look forward to helping the team achieve its remarkable vision for success."
Stephen Squinto, Ph.D., has over 25 years of experience in the biotechnology industry, as both a scientist and senior executive. He is currently a Venture Partner with OrbiMed. Dr. Squinto was a co-founder of Alexion Pharmaceuticals Inc. and recently served as its Executive Vice President and Chief Global Operations Officer. Prior to 2013, he was Alexion's Global Head of Research and Development. Alexion is dedicated to developing therapies for certain rare and ultra-rare diseases. From 1988 to 1992, Dr. Squinto held various positions at Regeneron Pharmaceuticals, Inc. Prior to Regeneron, he held a joint academic position at both the Tulane University and LSU Medical Schools. He is a recipient of numerous honors and awards from academic and professional organizations for his scientific work. Dr. Squinto received his B.A. in Chemistry and Ph.D. in Biochemistry and Biophysics from Loyola University of Chicago.

Similar Profiles

Other People with this Name

Other people with the name Squinto

Stephen Squinto
Compass Therapeutics LLC

Adam Squinto
The Madison Square Garden Company

Eric Squinto
Burst.com Inc.

Adam Squinto
Loyola University

Eric Squinto
Northeastern University

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory